F19.97
Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance-induced major neurocognitive disorder, without use disorder
Medical Intelligence & Overview
ICD-10 Code F19.97 refers to a condition known as other psychoactive substance use, unspecified, with psychoactive substance-induced persisting dementia. This diagnosis highlights cases where long-term cognitive decline is linked to the use of various psychoactive substances, but without an active substance use disorder diagnosis. The condition signifies that persistent dementia symptoms are a consequence of substance use history, impacting mental functions such as memory, thinking, and reasoning, even after stopping the substance. This guide aims to provide a clear overview of what this diagnosis entails, its causes, symptoms, methods of diagnosis, and general approaches to management.
Causes & Symptoms
Clinical Causes: Chronic exposure to neurotoxic substances, such as alcohol or certain illicit drugs Repeated or heavy use leading to brain damage or neurochemical imbalances Age-related vulnerabilities combined with substance use history Pre-existing neurological conditions that may be exacerbated by substance use Environmental and psychosocial factors that influence substance consumption patterns
Key Symptoms: Memory impairment, especially recent or short-term recall deficits Difficulties with complex thinking or problem-solving Impaired executive functions, such as planning and decision-making Reduced attention span and concentration difficulties Disorientation to time or place Language disturbances, including word-finding difficulties Changes in personality or behavior, such as apathy or apathy Decline in daily functioning and independence
Diagnostic & Treatment
Diagnosis Path: Documenting history of psychoactive substance use, especially long-term or heavy use Assessing current cognitive functioning through standardized testing Excluding other causes of dementia, such as Alzheimer's disease or vascular dementia Neuroimaging studies (MRI or CT scans) to identify structural brain changes Evaluating for other medical or psychiatric conditions that may contribute to cognitive decline
Treatment Protocols: Cognitive rehabilitation to help maintain or improve mental functions Medication management for associated symptoms or comorbid conditions, as prescribed by healthcare providers Nutritional support and management of comorbid medical issues Psychosocial interventions, including counseling and support groups Encouraging abstinence from psychoactive substances to prevent further brain injury Educational programs for patients and caregivers to understand the condition and adaptation strategies
Clinical Advice & FAQs
Billing Guidance
Is F19.97 a billable ICD-10 code?
Yes, F19.97 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.97?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference